December 22, 2025

Small Shingles Risk Seen Post mRNA COVID-19 Booster

Researchers drew from more than 2 million Dutch primary care records.

Conexiant

December 19, 2025

Who Decides Vaccine Evidence Now?

A fight over data standards at the FDA raises urgent questions about vaccine safety, ethics, and trust.

KFF Health News

December 19, 2025

Measles Cases Surge to 25-Year High

US faces threat to measles elimination status as respiratory virus season intensifies with emergence of vaccine-evading H3N2 subclade

Conexiant

December 05, 2025

On the Edge of a Measles Comeback?

New analysis examines rising U.S. measles outbreaks, associated clinical risks, and the potential loss of measles-elimination status.

KFF Health News

April 18, 2024

New Research Defines Specific Genomic Changes Associated with the Transmissibility of the Monkeypox Virus

Mount Sinai scientists, in collaboration with researchers from the Carlos III Health Institute (ISCIII) in Madrid, Spain, have located and identified alterations in the monkeypox virus genome that potentially correlate with changes in the virus’s transmissibility observed in the 2022 outbreak.

Mount Sinai New York

September 16, 2021

COVID-19 webinar: Updates on COVID-19 variants, disease prevention and management

Mayo Clinic experts provide the latest information on various aspects of the COVID-19 pandemic. (Credit is available.)

Mayo Clinic

July 11, 2021

COVID-19 webinar: “Black fungus” in the Indian subcontinent – prevention and cure

Mayo Clinic experts discuss the COVID-19 associated rhino-orbital mucormycosis (“black fungus”) crisis in India. (Credit is available.)

Mayo Clinic

February 09, 2021

Adolfo García-Sastre, PhD, on Plitidepsin Clinical Efficacy Against SARS-CoV-2

In this video, Adolfo García-Sastre, PhD, describes the search to find drugs appropriate for repurposing against SARS-CoV-2 and the effectiveness of plitidepsin

Mount Sinai New York

December 17, 2020

Minorities in clinical trials

Mayo Clinic experts discuss how underrepresentation of minority groups in clinical trials affects the quality of research, with a special emphasis on COVID-19 research. (Credit is available.)

Mayo Clinic